pyrrolidonecarboxylic acid has been researched along with Dementia Praecox in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erden, F; Holubová, K; Horáček, J; Höschl, C; Mutlu, O; Páleníček, T; Pinterová, N; Šíchová, K; Stuchlík, A; Valeš, K | 1 |
| Guo, J; Huang, T; Liu, ML; Liu, Z; Meng, HQ; Mu, J; Xie, P; Xu, Y; Zheng, P | 1 |
| Arvanitis, L; Bauer, D; Meltzer, HY; Rein, W | 1 |
| Itoh, H; Kurachi, M; Matsuoka, T; Sumiyoshi, T; Tanaka, K; Tsunoda, M; Uehara, T | 1 |
| Cowen, MA | 1 |
1 trial(s) available for pyrrolidonecarboxylic acid and Dementia Praecox
| Article | Year |
|---|---|
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cannabinoids; Double-Blind Method; Drugs, Investigational; Female; Haloperidol; Humans; Male; Middle Aged; Neurotensin; Peptide Fragments; Piperidines; Placebos; Psychotic Disorders; Pyrazoles; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-3; Research Design; Rimonabant; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2004 |
4 other study(ies) available for pyrrolidonecarboxylic acid and Dementia Praecox
| Article | Year |
|---|---|
Effects of the adipokinetic hormone/red pigment-concentrating hormone (AKH/RPCH) family of peptides on MK-801-induced schizophrenia models.
Topics: Animals; Anti-Anxiety Agents; Disease Models, Animal; Dizocilpine Maleate; Insect Hormones; Male; Memory; Memory Disorders; Neuropeptides; Neuroprotective Agents; Oligopeptides; Peptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Long-Evans; Rats, Wistar; Schizophrenia | 2018 |
GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
Topics: Adult; alpha-Tocopherol; Biomarkers; Case-Control Studies; Energy Metabolism; Female; Gas Chromatography-Mass Spectrometry; Humans; Leukocytes, Mononuclear; Male; Metabolome; Metabolomics; Multivariate Analysis; Neurotransmitter Agents; Oxidative Stress; Pyrrolidonecarboxylic Acid; ROC Curve; Schizophrenia; Sorbitol; Young Adult | 2014 |
NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ataxia; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hyperkinesis; Male; Motor Activity; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Schizophrenia; Social Behavior Disorders; Stereotyped Behavior | 2005 |
Electrophysiological phenomena associated with the S-protein system in normal and schizophrenic subjects.
Topics: 5-Hydroxytryptophan; Adult; Alpha-Globulins; Animals; Chickens; Electrophysiology; Erythrocytes; Female; Frontal Lobe; Glutamates; Humans; In Vitro Techniques; Male; Middle Aged; Proline; Protein Conformation; Pyrrolidonecarboxylic Acid; Rats; Schizophrenia; Serotonin; Tryptophan | 1973 |